present
studi
gener
murin
monoclon
antibodi
mab
name
use
crude
outer
membran
protein
prepar
salmonella
enter
subsp
enterica
serovar
typhimurium
atcc
strain
antigen
belong
isotyp
demonstr
broad
crossreact
standard
isol
strain
genu
salmonella
other
escherichia
coli
klebsiella
pneumonia
proteu
mirabili
crossreact
across
sever
bacteri
genera
indic
epitop
reactiv
conserv
among
member
neutral
effect
salmonella
growth
surviv
evalu
vitro
use
bacteriostat
bactericid
activ
without
complement
bacteri
invas
inhibit
assay
demonstr
bacteriostat
effect
growth
typhimurium
atcc
strain
time
concentr
mab
depend
also
found
bacteri
growth
inhibit
complement
independ
bacteri
cell
preincub
reduc
adher
invas
bacteri
cell
epitheli
cell
line
confirm
cfu
count
analysi
phase
contrast
fluoresc
microscopi
scan
electron
microscop
sem
imag
confirm
antimicrobi
effect
typhimurium
atcc
develop
broadli
reactiv
cross
protect
open
new
possibl
immunotherapi
sepsi
caus
gramneg
enterobacteriacea
member
salmonella
import
genu
famili
enterobacteriacea
common
pathogen
bacteria
caus
diarrhea
gastroenter
typhoid
paratyphoid
fever
septicemia
clinic
syndrom
vari
degre
sever
di
febo
et
al
li
et
al
salmonella
commonli
found
intestin
tract
human
anim
therefor
presenc
salmonella
food
raw
materi
indic
fecal
contamin
certain
nontyphoid
salmonella
strain
respons
bloodstream
infect
refer
invas
nontyphoid
salmonella
int
infect
global
burden
diseas
injuri
risk
factor
studi
gbd
publish
salmonella
enterocol
result
million
case
death
symptom
typic
diarrhea
present
febril
ill
higher
fatal
rate
stanaway
et
al
diseas
burden
disproportion
affect
adult
children
weak
immun
system
intervent
control
infect
depend
rapid
detect
pathogen
follow
appropri
therapeut
intervent
antimicrobi
resist
sever
class
antibiot
penicillin
tetracyclin
fluoroquinolon
sulfonamid
aminoglycosid
cephalosporin
anoth
major
concern
treatment
salmonella
infect
lama
et
al
passiv
immun
success
use
altern
method
prophylaxi
sever
gastrointestin
pathogen
campylobact
salmonella
e
coli
rotaviru
coronaviru
esmailnejad
et
al
interest
toward
antibodybas
therapi
prompt
base
need
find
suitabl
altern
convent
antibiot
view
widespread
antimicrobi
resist
select
right
virul
factor
target
therapeut
intervent
play
key
role
diseas
control
sever
studi
shown
outer
membran
protein
omp
bacteria
strong
immunogen
compon
possibl
vaccin
candid
babu
et
al
abadi
et
al
neema
karunasagar
outer
membran
protein
includ
integr
membran
protein
well
lipoprotein
anchor
outer
membran
via
n
termin
attach
lipid
gener
omp
character
structur
integr
omp
essenti
maintain
integr
select
permeabl
bacteri
membran
lin
et
al
serv
adhesin
play
import
role
virul
ebank
et
al
khushiramani
et
al
outer
membran
protein
extrem
immunogen
li
et
al
therefor
would
effect
candid
vaccin
diagnost
develop
owe
expos
epitop
cell
surfac
omp
salmonella
also
known
signific
role
elicit
immun
respons
meenakshi
et
al
consid
potenti
candid
confer
protect
typhoid
salmonella
omp
investig
potenti
vaccin
candid
virul
factor
diagnost
antigen
isibasi
et
al
therefor
gener
antibodi
specif
surfac
structur
compon
might
prevent
establish
infect
present
studi
util
typhimurium
omp
prepar
antigen
choic
develop
mab
reactiv
member
genu
salmonella
one
monoclon
antibodi
name
function
character
sever
vitro
assay
studi
effect
mab
fight
salmonella
infect
preliminari
attempt
made
understand
abil
mab
block
pathogen
undertak
vivo
challeng
studi
crossreact
antibacteri
invas
inhibit
assay
perform
examin
antisalmonella
properti
monoclon
antibodi
dehydr
media
brain
heart
infus
broth
muellerhinton
broth
bacteri
propag
procur
himedia
laboratori
mumbai
india
cell
cultur
media
reagent
antibiot
procur
sigmaaldrich
india
inorgan
salt
organ
solvent
sisco
research
lab
india
bhi
broth
agar
use
cultur
propag
store
bacteri
strain
muellerhinton
media
use
bacteriostat
bactericid
assay
invasioninhibit
assay
bacteri
cultur
use
studi
grown
constant
agit
rpm
cell
line
propag
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
appropri
antibiot
maintain
co
crude
omp
prepar
overnight
cultur
typhimurium
atcc
describ
arora
et
al
briefli
typhimurium
grown
brain
heart
infus
broth
overnight
follow
harvest
cell
centrifug
cell
wash
pb
twice
dissolv
ml
mm
tri
contain
nacl
cell
subject
sonic
vibracel
sonic
sonic
materi
inc
newtown
ct
amplitud
ice
six
repetit
interv
lysat
subject
centrifug
min
follow
centrifug
supernat
h
pellet
suspend
mm
tri
contain
sodium
lauryl
sarcosin
sarkosyl
incub
overnight
crude
omp
extract
obtain
centrifug
omp
wash
distil
water
dissolv
pb
store
use
protein
concentr
determin
lowri
colorimetr
assay
gener
character
monoclon
antibodi
hybridoma
procedur
outer
membran
protein
prepar
extract
strain
typhimurium
atcc
use
immun
femal
balbc
mice
mice
maintain
light
dark
cycl
altern
mice
provid
food
pellet
commerci
vendor
miner
water
kent
water
purifi
given
mice
studi
period
rice
hull
use
bed
materi
chang
everi
day
two
femal
mice
hous
polypropylen
enclosur
fifti
microgram
quantiti
omp
administ
subcutan
emuls
freund
complet
adjuv
follow
two
booster
dose
quantiti
protein
emuls
freund
incomplet
adjuv
interv
antibodi
titer
determin
indirect
elisa
use
extract
omp
prepar
antigen
suffici
titer
reach
mice
sacrif
spleen
asept
dissect
collect
splenocyt
fuse
mous
myeloma
cell
line
pegyl
method
fuse
cell
propag
hat
medium
hybrid
screen
reactiv
omp
prepar
one
mab
name
show
strong
reactiv
separ
use
studi
purifi
grow
clone
dmem
supplement
fb
cm
cultur
flask
confluenc
cell
transfer
serumfre
media
grown
anoth
day
cellfre
cultur
supernat
separ
use
purifi
cell
cultur
supernat
cc
collect
clone
subject
centrifug
min
remov
cell
supernat
ml
treat
ammonium
sulfat
precipit
concentr
recoveri
mab
briefli
cc
th
volum
triscl
ph
ad
mix
mixtur
ammonium
sulfat
solut
ad
dropwis
continu
stir
mixtur
turn
turbid
requir
ml
mixtur
incub
h
solut
subject
centrifug
h
pellet
ml
ammonium
sulfat
solut
ad
mix
subject
centrifug
min
pellet
dissolv
ml
pb
excess
salt
remov
dialysi
volum
pb
solut
overnight
buffer
chang
least
three
dialysi
collect
concentr
mab
clone
final
purifi
homogen
use
protein
chromatographi
kit
sigmaaldrich
india
isotyp
determin
isoquick
mous
monoclon
antibodi
isotyp
kit
sigmaaldrich
india
concentr
divid
aliquot
subject
lyophil
futur
use
briefli
aliquot
frozen
frozen
sampl
place
lyophil
lyodel
delvac
pump
india
precool
subject
lyophil
psi
h
lyophil
sampl
store
use
complet
dri
sampl
dissolv
steril
distil
water
requir
pass
steril
syring
filter
pall
life
scienc
india
antibodi
concentr
quantifi
lowri
colorimetr
assay
use
bsa
standard
concentr
mab
adjust
mgml
sdspage
western
blot
analysi
carri
check
reactiv
differ
bacteri
strain
belong
enterobacteriacea
briefli
sdspage
perform
use
biorad
miniprotean
tetra
cell
apparatu
per
procedur
laemmli
minor
modif
one
millilit
overnight
bacteri
cell
harvest
centrifug
dissolv
equal
volum
pb
laemmli
buffer
bacteri
sampl
subject
boil
min
follow
centrifug
min
separ
cell
debri
ten
microlit
cell
lysat
supernat
load
sdspage
gel
resolv
v
separ
protein
resolv
gel
transfer
charg
nitrocellulos
membran
pall
life
scienc
electroblot
wet
transfer
biorad
mini
transblot
cell
v
min
blot
membran
block
skim
milk
solut
overnight
excess
milk
protein
wash
pbst
tween
solut
next
membran
incub
dilut
room
temperatur
gel
rocker
membran
wash
pbst
incub
goat
antimous
igg
conjug
hrp
dilut
wash
membran
pbst
blot
develop
use
diaminobenzidin
tetrahydrochlorid
hydrat
h
solut
pb
overnight
cultur
use
dot
elisa
five
hundr
microlit
volum
cultur
harvest
centrifug
follow
dissolv
bacteri
cell
equal
volum
carbonatebicarbon
buffer
ph
ten
microlit
cell
coat
onto
grid
cm
nitrocellulos
nc
strip
air
dri
min
nc
strip
block
milk
solut
h
room
temperatur
strip
wash
pbst
solut
time
incub
dilut
wash
membran
incub
goat
antiprimari
antibodi
conjug
hrp
membran
wash
pbst
develop
diaminobenzidin
dab
tetrahydrochlorid
sigmaaldrich
india
solut
h
pb
effect
surviv
growth
typhimurium
cc
eval
uat
bacteriostaticbactericid
assay
use
microtit
plate
typhimurium
atcc
strain
grown
overnight
muellerhinton
broth
mhb
cultur
dilut
cfuml
mhb
lyophil
reconstitut
steril
distil
water
adjust
concentr
mgml
mab
ad
salmonella
cultur
variou
concentr
mab
ad
mhb
mix
typhimurium
atcc
dilut
step
triplic
microtit
plate
lid
control
steril
mhb
mab
bacteri
cell
use
understand
mab
would
nonspecif
bind
bacteria
inhibit
growth
also
mix
enterobact
aerogen
atcc
triplic
mab
well
steril
mhb
use
blank
plate
incub
constant
shake
rpm
tecan
multimod
reader
absorb
read
nm
everi
hour
h
effect
complement
bactericid
activ
studi
ad
mous
complement
serum
blood
collect
unimmun
mice
retroorbit
punctur
blood
incub
h
follow
centrifug
min
separ
serum
serum
collect
store
use
complement
assay
perform
similar
bacteriostat
assay
except
serum
contain
complement
ad
well
along
mab
mhb
typhimurium
atcc
cell
describ
method
section
bacteriostaticbactericid
studi
microtit
plate
cover
kept
shake
rpm
h
absorb
read
nm
everi
h
invas
inhibit
assay
perform
human
alveolar
epitheli
cell
line
cell
grown
tissu
cultur
flask
confluenc
dmem
fb
suitabl
antibiot
co
cell
dislodg
trypsin
treatment
cell
centrifug
room
temperatur
min
cell
pellet
resuspend
fresh
dmem
fb
transfer
plate
incub
overnight
follow
day
cultur
supernat
remov
cell
wash
steril
pb
two
time
time
bacteri
cell
overnight
cultur
harvest
wash
pb
cell
dilut
cfuml
dmem
fb
similarli
mab
dilut
dmem
fb
equal
volum
bacteri
cultur
mab
mix
singl
steril
micro
centrifug
tube
incub
min
control
bacteri
cell
without
mab
use
mixtur
ad
along
equal
amount
dmem
media
supplement
fb
cell
plate
incub
co
incub
co
h
incub
media
remov
wash
steril
pb
twice
two
hundr
microlit
fresh
dmem
media
contain
gentamicin
ad
incub
min
media
remov
cell
wash
steril
pb
twice
cell
lyse
triton
cell
observ
microscop
confirm
lysi
lyse
cell
steril
pb
ad
mix
collect
asept
steril
micro
centrifug
tube
one
hundr
microlit
cultur
suspens
subject
pour
plate
plate
count
agar
along
appropri
control
plate
incub
h
coloni
count
cell
seed
describ
method
section
invas
inhibit
assay
plate
contain
gelatinco
glass
cover
slip
cell
incub
h
co
wash
steril
pb
dmem
media
mixtur
typhimurium
atcc
cultur
mab
describ
method
section
invas
inhibit
assay
ad
well
duplic
typhimurium
atcc
cell
ad
without
mab
control
bacteri
cell
allow
adher
h
co
unattach
bacteri
cell
remov
wash
time
ml
prewarm
steril
pb
five
hundr
microlit
dilut
fitc
secondari
conjug
ad
well
kept
h
room
temperatur
dark
place
well
wash
steril
pb
sever
time
cell
coverslip
fix
dip
formalin
dri
observ
phase
contrast
fluoresc
microscop
effect
mab
live
salmonella
cell
morpholog
observ
scan
electron
microscop
fei
model
quanta
analysi
briefli
typhimurium
atcc
grown
overnight
bhi
broth
bacteri
cell
wash
filtersteril
pb
adjust
cell
count
cfuml
hundr
microlit
cell
mix
mab
incub
h
bacteri
cell
without
mab
addit
use
control
monoclon
antibodi
treat
untreat
bacteri
cell
fix
conduct
dual
side
carbon
tape
coat
gold
use
sputter
coater
emitech
model
dri
co
chamber
chang
surfac
morpholog
structur
bacteri
cell
captur
environment
mode
sem
magnif
statist
analys
perform
use
microsoft
excel
elisa
experi
done
triplic
data
repres
mean
sd
statist
differ
differ
group
analyz
use
univari
anova
differ
p
consid
signific
separ
membran
protein
achiev
use
sarkosyl
method
found
optim
recov
omp
membran
ghatak
et
al
separ
extract
omp
show
sever
band
coomassi
brilliant
bluestain
sdspage
gel
rang
kda
fig
omp
concentr
found
mgml
lowri
assay
concentr
adjust
mgml
use
pb
diluent
outer
membran
protein
directli
administ
antigen
mice
antibodi
titer
increas
progress
booster
dose
crude
omp
prepar
primari
dose
follow
two
booster
dose
administ
antibodi
titer
serum
reach
dilut
high
antibodi
titer
indic
strong
immunogen
natur
omp
prepar
serum
antibodi
unimmun
mice
show
reactiv
crude
omp
polyclon
antibodi
serum
react
whole
typhimurium
cell
dot
elisa
fig
serum
normal
mice
show
reactiv
fig
five
monoclon
antibodi
clone
exhibit
reactiv
typhimurium
omp
prepar
test
cell
supernat
indirect
elisa
microtit
plate
five
hybridoma
reactiv
one
mab
name
particularli
strike
clone
expand
test
reactiv
sever
whole
cell
whole
cell
lysat
typhimurium
dot
elisa
western
blot
analysi
respect
mab
show
reactiv
test
standard
isol
typhimurium
strain
dot
elisa
fig
show
distinct
reactiv
kda
region
western
blot
analysi
fig
properti
character
assess
isotyp
reactiv
differ
salmonella
speci
close
relat
member
salmonella
isotyp
analysi
reveal
clone
belong
subclass
antibodi
precipit
concentr
procedur
affect
reactiv
monoclon
antibodi
display
reactiv
test
salmonella
speci
typhimurium
typhi
infanti
enteritidi
newportii
bovismorbifican
paratyphi
western
blot
analysi
fig
due
conserv
natur
epitop
opinion
antigen
react
mab
might
outer
membran
protein
omp
present
salmonella
serovar
reactiv
seen
distinct
protein
band
develop
blot
kda
region
reactiv
test
nonsalmonella
member
escherichia
coli
shigella
spp
klebsiella
pneumonia
proteu
spp
enterobact
aerogen
mab
found
react
e
coli
proteu
spp
fig
band
organ
also
found
kda
except
e
coli
found
less
kda
western
blot
pattern
observ
salmonella
share
common
antigen
h
e
r
u
e
r
e
b
r
n
e
w
h
h
e
r
e
b
e
r
f
enterobacteriacea
sinc
found
reactiv
omp
differ
salmonella
serovar
investig
mab
possess
bacteriostat
bactericid
properti
util
standard
typhimurium
atcc
strain
test
antimicrobi
activ
standard
dilut
cfuwel
mh
broth
differ
dilut
mab
incub
h
found
mab
abl
control
growth
bacteria
temporarili
visibl
growth
well
howev
differ
optic
densiti
clear
vari
concentr
mab
figur
growth
bacteria
reduc
consider
word
growth
inhibit
complet
stop
growth
resum
h
inocul
control
well
bacteria
mab
growth
resum
immedi
decreas
mab
concentr
time
laps
control
well
mabtreat
well
decreas
confirm
specif
inhibitori
effect
salmonella
salmonella
cell
treat
control
mab
mous
monoclon
antihistidin
antibodysigma
aldrich
affect
growth
bacteria
untreat
control
therefor
conclud
inhibitori
effect
mab
time
concentr
depend
also
growth
bacteria
inhibit
h
indefinit
indic
effect
bacteriostat
complement
part
innat
immun
system
brought
work
adapt
humor
immun
system
complement
enhanc
activ
antibodi
phagocyt
cell
clear
pathogen
promot
inflamm
attack
pathogen
cell
membran
therefor
investig
whether
bacteriostat
effect
mab
complement
depend
collect
mous
serum
contain
complement
use
directli
conduct
growth
curv
assay
mention
along
complement
ad
well
figur
show
effect
mous
complement
system
bacteriostat
effect
mab
reveal
improv
reduct
growth
well
contain
complement
adher
intestin
epitheli
cell
first
step
invas
process
intestin
pathogen
investig
whether
mab
present
studi
would
inhibit
pathogen
invad
host
cell
one
batch
cell
line
epitheli
cell
line
grown
tissu
cultur
plate
cfu
count
analysi
anoth
batch
grown
cover
slip
microscopi
incub
cell
line
without
mab
adher
bacteri
cell
wash
antibiot
bacteri
cell
invad
host
cell
line
enumer
lysi
simultan
invas
observ
fluoresc
microscop
found
bacteri
cell
found
invad
absenc
mab
presenc
mab
inhibit
salmonella
invas
observ
tabl
bacteri
cell
preincub
mab
bacteriostat
concentr
fail
invad
cell
henc
coloni
observ
cell
line
lyse
plate
plate
count
agar
tabl
also
observ
invas
bacteri
cell
phase
contrast
fluoresc
microscop
found
cell
incub
pathogen
alon
damag
cell
membran
fig
observ
fig
bacteriostaticbactericid
potenti
test
microtiterbas
antimicrobi
assay
exhibit
bacteriostat
properti
concentr
antibacteri
activ
concentr
time
depend
fig
bacteriostaticbactericid
potenti
test
presenc
mous
complement
microtiterbas
antimicrobi
assay
presenc
serum
complement
improv
bacteriostat
properti
cell
leak
cytoplasm
content
due
cellular
damag
made
pathogen
bacteria
contrast
cell
line
intact
invad
pathogen
preincub
mab
fig
c
mabtreat
salmonella
exhibit
distinct
morpholog
alter
comparison
untreat
bacteri
cell
control
cell
intact
homogen
turgid
smooth
membran
fig
monoclon
antibodytr
salmonella
cell
show
sever
morpholog
alter
flaccidsquash
cell
uneven
wrinkl
protuber
crater
collaps
membran
disrupt
cell
content
fig
addit
mous
complement
favor
morpholog
damag
bacteriostat
concentr
monoclon
antibodi
increas
incub
time
promot
damag
cell
membran
mab
fig
infer
abl
bind
outer
membran
protein
disrupt
integr
cell
membran
global
salmonella
predomin
caus
typhoid
nontyphoid
gastroenter
infect
lead
signific
mortal
morbid
liu
et
al
nontyphoid
salmonella
alon
million
case
gastroenter
worldwid
annual
eng
et
al
emerg
multidrugresist
strain
limit
antibiot
treatment
option
vaccin
present
attract
approach
control
prevent
salmonellaassoci
diseas
sever
report
vaccin
experiment
present
develop
report
anim
human
studi
support
possibl
safe
effect
vaccin
invas
nontyphoid
salmonella
studi
anim
model
demonstr
efficaci
oantigen
flagellin
protein
outer
membran
protein
typhimurium
enteritidi
serovar
tennant
et
al
though
live
attenu
vaccin
abl
confer
cross
protect
risk
virul
restor
immunecompromis
individu
limit
use
haesebrouck
et
al
led
focu
develop
novel
altern
antimicrobi
therapi
offer
high
specif
improv
safeti
less
toxic
broad
immun
crossprotect
efficaci
broad
salmonella
serovar
passiv
immun
util
success
suitabl
altern
convent
antibiot
therapi
sever
gastrointestin
pathogen
salmonella
campylobact
escherichia
coli
rotaviru
esmailnejad
et
al
rahimi
et
al
antibodi
exert
antimicrobi
activ
bind
block
pathogen
entri
neutral
inhibit
growth
replic
dissemin
membran
damag
peddayelachagiri
et
al
kovacsnolan
mine
esmailnejad
et
al
monoclon
antibodi
found
way
immunodiagnost
pathogen
identif
prevent
therapeut
applic
administr
monoclon
antibodi
rais
conserv
antigen
enterobacteriacea
member
might
confer
neutral
effect
antibodydepend
cellular
cytotox
adcc
effect
sever
earlier
studi
explor
possibl
immunotherapi
util
crossreact
monoclon
antibodi
broad
rang
enterobacteriacea
pathogen
murin
monoclon
antibodi
capabl
bind
lp
e
coli
salmonella
shown
vitro
vivo
crossprotect
activ
lpsinduc
lethal
mous
model
di
padova
et
al
anoth
studi
two
monoclon
antibodi
direct
opolysaccharid
typhimurium
lp
provid
signific
protect
lethal
challeng
homolog
typhimurium
strain
mice
colwel
et
al
michetti
et
al
report
protect
efficaci
secretori
iga
challeng
invas
typhimurium
immun
exclus
mucos
surfac
similar
studi
perman
secret
mucos
iga
mab
direct
specif
antigen
respiratori
tract
backpack
tumor
model
protect
anim
challeng
high
dose
enteritidi
strain
intranas
rout
iankov
et
al
work
agreement
studi
wherein
crossreact
surfac
protein
target
monoclon
antibodi
neutral
pathogen
therebi
block
entri
cell
monoclon
antibodi
reactiv
sever
speci
salmonella
dot
elisa
western
blot
analysi
sinc
sever
member
famili
enterobacteriacea
close
relat
structur
composit
virul
mechan
test
crossreact
monoclon
antibodi
member
genu
klebsiella
proteu
escherichia
enterobact
monoclon
bodi
show
strong
crossreact
k
pneumonia
p
vulgari
e
coli
indic
share
epitop
among
organ
crossreact
pathogen
also
great
clinic
signific
western
blot
analysi
reveal
size
similar
crossreact
antigen
among
test
pathogen
salmonella
member
antigen
reactiv
assum
proteinac
natur
lipopolysaccharid
lp
base
distinct
band
pattern
reactiv
oppos
ladderlik
format
usual
associ
lp
peddayelachagiri
et
al
antibodi
direct
bacteri
surfac
compon
might
prevent
pathogen
establish
infect
block
bind
site
adhes
invas
host
cell
effect
reflect
vitro
rate
growth
surviv
bacteria
observ
vitro
condit
inhibit
growth
activ
divid
salmonella
bacteria
h
quantiti
assum
effect
vivo
condit
would
suffici
induc
opson
pathogen
neutral
hypothesi
need
studi
vivo
suitabl
anim
model
mab
bound
pathogen
surfac
block
invas
epitheli
cell
line
adhes
fig
studi
effect
morpholog
typhimurium
scan
electron
microscop
salmonella
bacteria
without
mab
incub
control
b
salmonella
cell
incub
h
c
salmonella
cell
incub
h
bacteria
cell
surfac
primari
step
establish
infect
prevent
bacteri
invas
promis
prevent
establish
pat
hogenesi
peddayelachagiri
et
al
subclass
mab
might
display
potent
neutral
phagocyt
kill
abil
vivo
sem
studi
complement
assumpt
surfac
locat
antigen
specif
electron
micrograph
clearli
evid
mab
bound
surfac
epitop
induc
osmot
lysi
bacteri
cell
demonstr
partial
bacteriostat
action
conclus
work
result
develop
broadli
reactiv
member
famili
enterobacteriacea
demonstr
bacteriostat
properti
salmonella
speci
vitro
condit
demonstr
broadli
crossreact
bacteriostat
invas
inhibitori
properti
due
share
e
p
p
e
n
g
n
p
h
g
e
n
c
e
b
e
r
f
enterobacteriacea
could
explor
valuabl
therapeut
tool
howev
addit
thorough
vivo
preclin
clinic
valid
need
perform
realiz
antibodi
therapi
approach
recombin
singlechain
variabl
fragment
scfv
antibodi
human
strategi
may
also
explor
ident
antigen
epitop
bind
also
need
identifi
